To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
Biomimetism and Regenerative Medicine Team (BRM)
Invasion Mechanisms in Angiogenesis and Cancer team (IMAC)
Mechanisms of Angiogenesis in Biological Barriers team (MAB2)
highlight / actuality
Researchers at our laboratory identified inhibitors of protein kinase CK2 and Pim which explain their extreme specificity. Simultaneous inhibition of both kinases could lead to new therapeutic perspectives in prostate cancer.
Top page
Thesis presented November 23, 2009 by Renaud Prudent.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.
Researchers at our laboratory identified inhibitors of protein kinase CK2 and Pim which explain their extreme specificity. Simultaneous inhibition of both kinases could lead to new therapeutic perspectives in prostate cancer.